What are the recommended dosages of pseudoephedrine and Bromphen DM (brompheniramine/dextromethorphan) for adults and for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bromphen DM and Pseudoephedrine Dosing

For Bromphen DM (brompheniramine/dextromethorphan combination), use the FDA-approved dosing: adults and children ≥12 years take 10 mL every 4 hours; children 6-11 years take 5 mL every 4 hours; children 2-5 years take 2.5 mL every 4 hours; maximum 6 doses per 24 hours. 1

Adult Dosing

Bromphen DM

  • Adults and children ≥12 years: 10 mL (2 teaspoonfuls) every 4 hours
  • Maximum: 6 doses in 24 hours 1

Pseudoephedrine (when used separately)

  • Adults and children ≥12 years: 2 tablets (60 mg each) every 4-6 hours
  • Maximum: 8 tablets (480 mg) in 24 hours 2

Pediatric Dosing

Bromphen DM

  • Children 6 to <12 years: 5 mL (1 teaspoonful) every 4 hours
  • Children 2 to <6 years: 2.5 mL (½ teaspoonful) every 4 hours
  • Infants 6 months to <2 years: Dosage must be established by physician
  • Maximum: 6 doses in 24 hours for all age groups 1

Pseudoephedrine (when used separately)

  • Children 6-11 years: 1 tablet (30 mg) every 4-6 hours
  • Maximum: 4 tablets (120 mg) in 24 hours
  • Children <6 years: Do not use 2

Critical Safety Considerations

Serotonin syndrome risk: The combination of dextromethorphan (in Bromphen DM) with SSRIs like sertraline can precipitate serotonin syndrome even at therapeutic doses. Watch for confusion, dilated pupils, myoclonus, and speech difficulties. If these occur, immediately discontinue both medications. 3

Pseudoephedrine cardiovascular effects: Expect heart rate increases of 2-4 beats per minute above baseline. Monitor for tachycardia, hypertension, and cardiac arrhythmias, particularly in patients with pre-existing cardiovascular disease. 4

Sedation profile: Brompheniramine (first-generation antihistamine) causes significantly more drowsiness than non-sedating alternatives. This sedation is dose-dependent and cumulative with multiple doses. 5

Pharmacokinetic Considerations

The elimination half-life of pseudoephedrine in children (3.1 ± 0.5 hours) is significantly shorter than in adults, explaining the need for more frequent dosing intervals in pediatric populations. 6 Weight-adjusted clearance remains independent of age in children 4-11 years, supporting consistent mg/kg dosing across this age range. 7

Efficacy Context

For cough suppression: Dextromethorphan demonstrates efficacy in chronic bronchitis but has limited benefit for acute upper respiratory infection cough. The generally recommended dosage is likely subtherapeutic; maximum cough reflex suppression occurs at 60 mg with prolonged effect. 8

For nasal congestion: Pseudoephedrine 60 mg provides statistically significant reduction in nasal airway resistance compared to placebo after both single and multiple doses, with effects measurable by objective rhinomanometry. 4

Antihistamine component: Chlorpheniramine (similar to brompheniramine) exhibits higher efficacy for rhinorrhea and general cold symptoms compared to pseudoephedrine alone, though with increased sedation. 9

Overdose Management

Toxic manifestations: Dextromethorphan overdose causes drowsiness, ataxia, nystagmus, and seizures. Brompheniramine overdose ranges from CNS depression to stimulation (especially in children) with anticholinergic effects. Pseudoephedrine toxicity presents as CNS stimulation, tachycardia, hypertension, and arrhythmias. 1

Treatment approach: If alert and presenting within 6 hours, induce emesis with aspiration precautions. Naloxone 0.005 mg/kg IV may reverse dextromethorphan-induced CNS depression. Use short-acting IV barbiturates for CNS hyperactivity or seizures. Manage hypertension and tachycardia appropriately with supportive care. 1

Related Questions

What are the dosing guidelines, indications, and contraindications for Pseudoeph‑Bromphen‑DM (pseudoephedrine 30 mg, brompheniramine 2 mg, dextromethorphan 10 mg per 5 mL) oral syrup?
What are the dosing guidelines for Bromfed (brompheniramine + dextromethorphan + pseudoephedrine) in adults, children of various age groups, and infants, and what precautions should be observed?
What dose of Bromfed (brompheniramine/pseudoephedrine) should be given to a child weighing 11.1 kg?
What dose of Bromfed DM (brompheniramine, pseudoephedrine, dextromethorphan) syrup is appropriate for a child weighing 60 lb (≈27 kg)?
What is the appropriate Bromfed (brompheniramine/pseudoephedrine) dose for a 47‑lb (≈21‑kg) child?
What is the most likely diagnosis and appropriate work‑up for a patient with low mean corpuscular hemoglobin (MCH) 26.4 pg, low mean corpuscular hemoglobin concentration (MCHC) 30.5 g/dL, elevated red cell distribution width (RDW) 19.3 %, increased platelet count 479 ×10⁹/L, and normal hemoglobin, hematocrit, and mean corpuscular volume (MCV)?
What alternative diabetes treatment options are appropriate for a pre‑menopausal woman who cannot afford glucagon‑like peptide‑1 (GLP‑1) receptor agonists or sodium‑glucose cotransporter‑2 (SGLT2) inhibitors and does not want metformin?
What is the appropriate dosing regimen of pregabalin (Lyrica) for neuropathic pain?
In a 29‑year‑old woman with high academic achievement who reports pervasive over‑analysis, distractibility, difficulty staying on task, multitasking to the point of constant overwhelm, significant anxiety, frequent interruptions of others, finger‑picking, and inability to sit still that worsened after a recent change in environment, what is the most likely diagnosis and what initial evaluation and management steps are recommended?
What is the link to the European Respiratory Society 2026 guidelines for pulmonary arterial hypertension?
Which sleep aid has minimal hepatic metabolism and does not adversely affect liver function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.